CCO Infectious Disease Podcast

Podcast on Addressing Social Determinants: Strategies to Support PrEP Persistence and Reengagement

Episode Summary

Hear from Beatriz Grinsztejn, MD, PhD, in this case-based discussion on the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women.

Episode Notes

In this episode, Beatriz Grinsztejn, MD, PhD, discusses the data and recommendations for addressing social determinants as a strategy to support PrEP persistence and engagement for transgender women, including: 

• HIV prevalence among transgender women
• Data on the PrEP cascade from the PrEParadas study of daily FTC/TDF among transgender women
• Data from the ImPrEP Study on early loss to follow-up, adherence, long-term engagement, and HIV incidence among transgender women
• Barriers to PrEP uptake and adherence for transgender women
• Drug–drug interactions between PrEP and feminizing hormone therapy
• Increasing PrEP uptake and retention with peer health navigation for transgender women

Faculty

Beatriz Grinsztejn, MD, PhD
Director
HIV/STI Clinical Research Laboratory
Instituto Nacional de Infectologia Evandro Chagas-Fiocruz
Rio de Janeiro, Brazil
IAS President-Elect

Link to full program:
https://bit.ly/3ZlICsL